Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Jul;308(1):61-5.
doi: 10.1007/BF00499720.

Effect of physostigmine and atropine on acetylcholine turnover in mouse brain

Effect of physostigmine and atropine on acetylcholine turnover in mouse brain

B Karlén et al. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jul.

Abstract

The effect of physostigmine salicylate (0.5 mg/kg, i.p.) alone and in combination with atropine sulfate (25 mg/kg, i.p.) on levels of acetylcholine (ACh) and choline (Ch) and turnover of ACh has been studied in whole brain and striatum of mice. The animals were killed by focussed microwave irradiation and the turnover of ACh was studied after i.v. injection of deuterium labelled Ch by employing mass fragmentography. Physostigmine increased the levels of ACh in whole brain from 24.5--28.0 nmol/g(P less than 0.001) whereas there was no significant increase in striatum. The levels of Ch were also increased. The turnover rate of ACh was decreased in whole brain from 15.4 to 8.4 and in striatum from 52.9 to 24.4 nmol/g . min. Physostigmine given before or after atropine did not completely block the ACh lowering effect of atropine. When atropine was given before physostigmine the turnover rate of ACh in whole brain was increased to 24.2 nmoles/g . min. The results seem to indicate that there is no clear cut relation between the turnover rate and level of ACh in vivo. The increase of the turnover rate induced by atropine is masked unless a cholinesterase inhibitor is given to protect the newly synthesized labelled ACh released by atropine.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol Chemother. 1964 Aug;23:123-30 - PubMed
    1. J Neurochem. 1976 Dec;27(6):1375-8 - PubMed
    1. Am J Med. 1960 Nov;29:832-48 - PubMed
    1. Eur J Pharmacol. 1975 Jun-Jul;32(02):287-92 - PubMed
    1. Life Sci. 1977 May 15;20(10):1651-5 - PubMed